INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 729 | -98.3% | 0.00% | – |
| Q1 2022 | $48,000 | -48.9% | 41,729 | 0.0% | 0.00% | – |
| Q4 2021 | $94,000 | -34.3% | 41,729 | -0.5% | 0.00% | – |
| Q3 2021 | $143,000 | -36.2% | 41,936 | -44.1% | 0.00% | – |
| Q2 2021 | $224,000 | +54.5% | 75,000 | +67.4% | 0.00% | – |
| Q1 2017 | $145,000 | +141.7% | 44,801 | +0.0% | 0.00% | – |
| Q4 2016 | $60,000 | -14.3% | 44,800 | 0.0% | 0.00% | – |
| Q3 2016 | $70,000 | +16.7% | 44,800 | 0.0% | 0.00% | – |
| Q2 2016 | $60,000 | -74.6% | 44,800 | 0.0% | 0.00% | – |
| Q1 2016 | $236,000 | -33.0% | 44,800 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $352,000 | -7.1% | 44,800 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $379,000 | -34.8% | 44,800 | -15.6% | 0.00% | 0.0% |
| Q2 2015 | $581,000 | +98.3% | 53,082 | +153.4% | 0.00% | – |
| Q1 2015 | $293,000 | – | 20,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
| EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
| ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |